| Name | neuritin 1-like |
| Description | The protein encoded by this gene is extracellular and enhances both neurite growth and neuronal survival. The encoded protein is found both as a GPI anchored membrane-bound form and as a secreted form. This activity-related ligand functions as a homodimer or heterodimer. [provided by RefSeq, Feb 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nFatty acid amide hydrolase (FAAH) is a critical metabolic enzyme that terminates endocannabinoid signaling by hydrolyzing bioactive lipids such as anandamide. In the brain its discrete cellular distribution—often in juxtaposition with cannabinoid receptors—enables local, precise control of retrograde synaptic communication and neural plasticity. Such regional localization has been demonstrated through detailed neuroanatomical mapping, which suggests that FAAH activity can restrict or extend endocannabinoid signaling depending on the local interplay between enzyme‐rich cell bodies and CB1‐expressing fibers."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn preclinical models FAAH deletion or pharmacological blockade elevates anandamide tone, which in turn enhances extinction of conditioned fear, reduces anxiety‐like behavior, and exerts antidepressant effects. The mechanistic basis of these observations points to increased activation of cannabinoid CB1 receptors as well as modulation of serotonergic transmission (and associated postsynaptic receptor adaptations), indicating that FAAH inhibition may offer a promising strategy for alleviating stress‐ and mood‐related disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFAAH’s role is not limited to the central nervous system. In peripheral tissues, FAAH governs processes as diverse as early embryonic development and oviductal transport, intestinal motility, and hepatocellular protection. In mouse models, disruption of FAAH perturbs the “anandamide tone” that is essential for proper embryo implantation, modulates gut peristalsis, and shields hepatocytes from endocannabinoid‐induced oxidative stress and cell death. In the cardiovascular system, FAAH deletion alters sensitivity to anandamide‐induced hypotension and affects myocardial responsiveness—underlining its importance in vascular homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its direct effects on endocannabinoid hydrolysis, modulation of FAAH has broader metabolic and analgesic implications. Experimental FAAH blockade in rodents increases ethanol preference and alters nociceptive thresholds, while also contributing to the efficacy of dual-target approaches (for example, simultaneous inhibition of FAAH and cyclooxygenases) for controlling inflammatory states. These studies collectively underscore FAAH’s capacity to influence energy homeostasis, nociception, and even aspects of cardiovascular risk."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFAAH activity also impacts sleep regulation and central adaptations to repeated cannabinoid exposure. In FAAH knockout animals, altered endocannabinoid levels correlate with modifications in sleep architecture, and pharmacological studies have illustrated that FAAH inhibition can adjust withdrawal profiles after cannabinoid administration. Moreover, FAAH’s role extends to the modulation of neuroinflammatory responses by influencing glial cell functions, which may have therapeutic implications for disorders such as Alzheimer’s disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nNotably, emerging evidence also implicates members of the neuritin (CPG15) family in neural development and synaptic plasticity. The recently identified paralogue cpg15‐2—also referred to as NRN1L—is expressed predominantly in the retina and olfactory bulb, and its activity appears to promote neurite outgrowth, neuronal survival, and synaptic maturation. The distinct spatial and temporal expression patterns of cpg15‐2 relative to its paralogue suggest that NRN1L may play a divergent yet complementary role in orchestrating the development and function of neural circuits."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, integrative studies reveal that targeting FAAH not only alters endocannabinoid metabolism but also reshapes the broader lipidome, affecting levels of structurally related bioactive lipids and influencing inflammatory responses and tissue repair. These comprehensive metabolic effects—ranging from modulation of hepatic energy homeostasis to enhancement of wound healing—further attest to the multifaceted role of FAAH and, by extension, to the regulatory potential shared by related factors such as NRN1L."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "M Egertová, B F Cravatt, M R Elphick "}, {"type": "b", "children": [{"type": "t", "text": "Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0306-4522(03)00145-3"}], "href": "https://doi.org/10.1016/s0306-4522(03"}, {"type": "t", "text": "00145-3) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12770562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12770562"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Stephen A Varvel, Laura E Wise, Floride Niyuhire, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.npp.1301224"}], "href": "https://doi.org/10.1038/sj.npp.1301224"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17047668"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17047668"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Fabricio A Moreira, Nadine Kaiser, Krisztina Monory, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropharmacology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuropharm.2007.07.005"}], "href": "https://doi.org/10.1016/j.neuropharm.2007.07.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17709120"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17709120"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "M N Hill, S A Kumar, S B Filipski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2012.90"}], "href": "https://doi.org/10.1038/mp.2012.90"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22776900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22776900"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Francis Rodriguez Bambico, Tommaso Cassano, Sergio Dominguez-Lopez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/npp.2010.80"}], "href": "https://doi.org/10.1038/npp.2010.80"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20571484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20571484"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yuri A Blednov, Benjamin F Cravatt, Stephen L Boehm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.npp.1301274"}], "href": "https://doi.org/10.1038/sj.npp.1301274"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17164820"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17164820"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Katherine W Falenski, Andrew J Thorpe, Joel E Schlosburg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/npp.2010.44"}], "href": "https://doi.org/10.1038/npp.2010.44"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20357755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20357755"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Young Taek Oh, Jung Yeon Lee, Jinhwa Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neulet.2010.03.026"}], "href": "https://doi.org/10.1016/j.neulet.2010.03.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20298753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20298753"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tommaso Cassano, Silvana Gaetani, Teresa Macheda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychopharmacology (Berl) (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00213-010-2051-0"}], "href": "https://doi.org/10.1007/s00213-010-2051-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21042794"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21042794"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Haibin Wang, Huirong Xie, Yong Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatty acid amide hydrolase deficiency limits early pregnancy events."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI28621"}], "href": "https://doi.org/10.1172/JCI28621"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16886060"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16886060"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Raffaele Capasso, Isabel Matias, Beat Lutz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatty acid amide hydrolase controls mouse intestinal motility in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2005.06.018"}], "href": "https://doi.org/10.1053/j.gastro.2005.06.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16143133"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16143133"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Sören V Siegmund, Ekihiro Seki, Yosuke Osawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatty acid amide hydrolase determines anandamide-induced cell death in the liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M509706200"}], "href": "https://doi.org/10.1074/jbc.M509706200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16418162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16418162"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Pál Pacher, Sándor Bátkai, Douglas Osei-Hyiaman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00107.2005"}], "href": "https://doi.org/10.1152/ajpheart.00107.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15821037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15821037"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Partha Mukhopadhyay, Bėla Horváth, Mohanraj Rajesh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2010.11.002"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2010.11.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21070851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21070851"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Lamont Booker, Steven G Kinsey, Rehab A Abdullah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1476-5381.2011.01445.x"}], "href": "https://doi.org/10.1111/j.1476-5381.2011.01445.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21506952"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21506952"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Oscar Sasso, Marco Migliore, Damien Habrant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.15-270637"}], "href": "https://doi.org/10.1096/fj.15-270637"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25757568"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25757568"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sébastien Lenglet, Aurélien Thomas, Oliver Soehnlein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.112.300275"}], "href": "https://doi.org/10.1161/ATVBAHA.112.300275"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23241405"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23241405"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Daniela Wenzel, Michaela Matthey, Laura Bindila, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1308130110"}], "href": "https://doi.org/10.1073/pnas.1308130110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24167249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24167249"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "A Straiker, J Wager-Miller, S S Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1476-5381.2011.01486.x"}], "href": "https://doi.org/10.1111/j.1476-5381.2011.01486.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21564090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21564090"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lawrence M Carey, Richard A Slivicki, Emma Leishman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pain (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1744806916649192"}], "href": "https://doi.org/10.1177/1744806916649192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27178246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27178246"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Emma Leishman, Ben Cornett, Karl Spork, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.phrs.2016.04.020"}], "href": "https://doi.org/10.1016/j.phrs.2016.04.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27109320"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27109320"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Salvador Huitron-Resendiz, Manuel Sanchez-Alavez, Derek N Wills, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sleep (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/sleep/27.5.857"}], "href": "https://doi.org/10.1093/sleep/27.5.857"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15453543"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15453543"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "D de Filippis, T Iuvone, A d'amico, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogastroenterol Motil (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2982.2008.01114.x"}], "href": "https://doi.org/10.1111/j.1365-2982.2008.01114.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18373655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18373655"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Cristina Benito, Rosa María Tolón, Ana Isabel Castillo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1476-5381.2012.01889.x"}], "href": "https://doi.org/10.1111/j.1476-5381.2012.01889.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22321194"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22321194"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Tadahiro Fujino, Zhen Wu, Walter C Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "cpg15 and cpg15-2 constitute a family of activity-regulated ligands expressed differentially in the nervous system to promote neurite growth and neuronal survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Comp Neurol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cne.21649"}], "href": "https://doi.org/10.1002/cne.21649"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18265009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18265009"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Xiaofei Sun, Haibin Wang, Masaru Okabe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic loss of Faah compromises male fertility in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Reprod (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1095/biolreprod.108.072736"}], "href": "https://doi.org/10.1095/biolreprod.108.072736"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18987328"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18987328"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Mireille Alhouayek, Pauline Bottemanne, Alexandros Makriyannis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Cell Biol Lipids (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbalip.2017.01.001"}], "href": "https://doi.org/10.1016/j.bbalip.2017.01.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28065729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28065729"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Oscar Sasso, Silvia Pontis, Andrea Armirotti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endogenous N-acyl taurines regulate skin wound healing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1605578113"}], "href": "https://doi.org/10.1073/pnas.1605578113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27412859"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27412859"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Pedro H Gobira, Isabel V Lima, Luara A Batista, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Psychopharmacol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0269881117691567"}], "href": "https://doi.org/10.1177/0269881117691567"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28583049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28583049"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Kwannok Leung, Matthew W Elmes, Sherrye T Glaser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of FAAH-like anandamide transporter in anandamide inactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0079355"}], "href": "https://doi.org/10.1371/journal.pone.0079355"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24223930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24223930"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Sören V Siegmund, Alexandra Wojtalla, Monika Schlosser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2013.06.033"}], "href": "https://doi.org/10.1016/j.bbrc.2013.06.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23806692"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23806692"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "S T Glaser, M Kaczocha "}, {"type": "b", "children": [{"type": "t", "text": "Temporal changes in mouse brain fatty acid amide hydrolase activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroscience.2009.06.043"}], "href": "https://doi.org/10.1016/j.neuroscience.2009.06.043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19555737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19555737"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Joon T Kim, Stephanie M Terrell, Veronica L Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cooperative enzymatic control of N-acyl amino acids by PM20D1 and FAAH."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.55211"}], "href": "https://doi.org/10.7554/eLife.55211"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32271712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32271712"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Romain Dalmann, Laurence Daulhac, Myriam Antri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropharmacology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuropharm.2014.11.006"}], "href": "https://doi.org/10.1016/j.neuropharm.2014.11.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25448494"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25448494"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "F Ativie, O Albayram, K Bach, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced microglial activity in FAAH(-/-) animals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2014.12.016"}], "href": "https://doi.org/10.1016/j.lfs.2014.12.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25534441"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25534441"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Anke M Mulder, Benjamin F Cravatt "}, {"type": "b", "children": [{"type": "t", "text": "Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi061122s"}], "href": "https://doi.org/10.1021/bi061122s"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16981687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16981687"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "William R Marrs, Eric A Horne, Silvia Ortega-Gutierrez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.202853"}], "href": "https://doi.org/10.1074/jbc.M110.202853"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21665953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21665953"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Sergio Domínguez-López, Rebecca Howell, Gabriella Gobbi "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of serotonin neurotransmission in knockout mice: implications for major depression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Rev Neurosci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/revneuro-2012-0044"}], "href": "https://doi.org/10.1515/revneuro-2012-0044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23089640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23089640"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Katrin Palumbo-Zerr, Angelika Horn, Alfiya Distler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Rheum Dis (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/annrheumdis-2012-201823"}], "href": "https://doi.org/10.1136/annrheumdis-2012-201823"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22915616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22915616"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Bhavapriya Vaitheesvaran, Li Yang, Kirsten Hartil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0033717"}], "href": "https://doi.org/10.1371/journal.pone.0033717"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22442717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22442717"}]}]}]}
|
| Synonyms | UNQ2446, MRCC2446, cpg15-2 |
| Proteins | NRN1L_HUMAN |
| NCBI Gene ID | 123904 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NRN1L has 2,768 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 71 datasets.
Click the + buttons to view associations for NRN1L from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NRN1L gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NRN1L gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NRN1L gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NRN1L gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NRN1L gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NRN1L gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NRN1L gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NRN1L gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NRN1L gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NRN1L gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NRN1L gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NRN1L gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NRN1L protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NRN1L protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NRN1L gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NRN1L gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with NRN1L gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NRN1L gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NRN1L gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NRN1L gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NRN1L gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NRN1L gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NRN1L gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NRN1L from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NRN1L gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NRN1L gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NRN1L gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NRN1L gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NRN1L gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NRN1L gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NRN1L gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NRN1L gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NRN1L gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NRN1L protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NRN1L gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NRN1L gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NRN1L gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NRN1L gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NRN1L gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NRN1L gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NRN1L gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NRN1L gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NRN1L protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NRN1L gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by NRN1L gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NRN1L protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NRN1L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NRN1L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NRN1L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NRN1L gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NRN1L gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NRN1L gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NRN1L protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NRN1L gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NRN1L gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NRN1L gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NRN1L gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NRN1L gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Reactome Pathways 2024 | pathways involving NRN1L protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NRN1L gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NRN1L gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NRN1L gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NRN1L gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NRN1L gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NRN1L gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NRN1L gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of NRN1L gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NRN1L gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NRN1L gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NRN1L protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NRN1L protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |